ARTICLE | Product Development
ARPA-H supports a new side of mRNA research
Emory-led project gains ARPA-H backing to control immune cell function in vivo by merging mRNA with CRISPR-based gene regulation
September 7, 2023 10:43 PM UTC
ARPA-H is envisioning a new way to use mRNA to drive immune responses that goes beyond traditional mRNA vaccine technology, and it’s the subject of the first project to gain funding through its call for proposals.
On Aug. 23, the Advanced Research Projects Agency for Health (ARPA-H) announced that the Curing the Uncurable via RNA-encoded Immunogene Turning (CUREIT) project was the first to be selected through its Open Broad Agency Announcement...